Research Paper Volume 15, Issue 18 pp 9633—9660
A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Figure 9. Risk model of the DEGTGs in LUAD. (A) Risk genes that affect patient prognosis in LUAD; (B–E) Patients with higher risk scores have the poor prognosis. Abbreviations: DEGTGs: differentially expressed Gefitinib target genes; LUAD: lung adenocarcinoma.